Recent Posts

Sun Pharma receives USFDA approval for ophthalmology product

The USFDA has granted an approval for Sun Pharma to start selling the generic version of Acular, ketorolac tromethamine ophthalmic solution, 0.5%.

Ketorolac tromethamine ophthalmic solution is prescribed to provide temporary relief of ocular itching due to seasonal allergic conjunctivitis, and also in treating post-operative inflammation in patients who have undergone cataract extraction.

Acular, a licensed medication of US-based Allergan, has annual sales of $40 million a year in the US.

Continue Reading →

Filed under: , , , , , ,